Welcome to EPG Patient Direct

The healthcare portal for patients and the general public in Europe

Welcome
  • Conditions and illnesses
  • Managing your health
  • Lifestyle advice
  • Treatment choices

Your Vote

Are you affected by second- hand smoke?
Yes
No

To read more about second hand smoke please click here

This service contains links to third party websites. EPG Patient Direct is not in a position to verify this information and cannot be held responsible for the accuracy of the content contained.

   

More NewsEPG Patient Direct News

Study shows diabetes tests discrepancies in kidney failure patients

22 Feb 2008

Standard blood glucose tests for diabetics are not an accurate measure of blood sugar levels in patients with kidney failure, research suggests.

According to a study carried out by Wake Forest University Baptist Medical Centre, the standard haemoglobin A1c test (HbA1c) underestimates true blood glucose control in hemodialysis patients.

Published in the journal Kidney International, Researchers focused on 307 patients with diabetes, 258 of these with end-stage kidney disease on haemodialysis and 49 without kidney failure.

The study compared the standard HbA1c test with a newer glycated albumin (GA) test which measures the amount of blood sugar that has reacted with albumin.

Diabetic patients on haemodialysis were found to have higher blood sugars and GA levels despite their lower HbA1c results.

Researchers believe the cause of this discrepancy is that HbA1c depends on red blood cell survival, particularly given that these cells do not live as long in haemodialysis patients.

"Control of blood sugar improves outcomes of diabetic patients, so accurate assessment is critical," said the study's lead author, Barry Freedman.

"This study supports the GA test as a more accurate measure of long-term blood sugar control among diabetic patients who are on haemodialysis."

High levels of blood glucose can present risk factors for developing hardening of the arteries (atherosclerosis) as well as kidney disease, heart attack, stroke, nerve damage and blindness, especially in diabetics undergoing haemodialysis

Click here to learn more about DiabetesADNFCR-1528-ID-18478052-ADNFCR

Email article E-mail    Bookmark Bookmark    Print Article Print

Delicious   Reddit Reddit   Facebook Facebook   StumbleUpon StumbleUpon  

Related News Stories (Diabetes)